diosgenin has been researched along with Diabetes Mellitus, Type 2 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, D; Dubey, SK; Katiyar, C; Krishna, KV; Narwaria, A; Taliyan, R; Tandon, N; Wadhwa, G; Yadav, SS | 1 |
| Lu, Z; Peng, JY; Wang, J; Yao, Y | 1 |
| Gao, L; He, S; Jin, R; Lei, M; Li, Z; Peng, X; Shi, C; Wang, X; Yao, Y; Zhong, Y | 1 |
| Chen, S; Dong, H; Fang, K; Gao, Y; Lu, F; Nie, K; Su, H; Tang, Y; Wang, H; Wang, Z | 1 |
| Han, X; Jin, Y; Liu, KX; Peng, JY; Qi, Y; Xu, LN; Xu, YW; Yin, LH; Zhao, YY | 1 |
| Bing, L; Xie, Y; Yu, F; Yu, W | 1 |
| Jayachandra Reddy, N; Kannan, M; Kumar, R; Sudha Rani, S; Tharaheswari, M; Varshney, KC | 1 |
7 other study(ies) available for diosgenin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
A novel UPLC-MS/MS method for simultaneous quantification of trigonelline, 4-hydroxyisoleucine, and diosgenin from Trigonella foenum-graecum extract: Application to pharmacokinetic study in healthy and type 2 diabetic rats.
Topics: Alkaloids; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diosgenin; Female; Isoleucine; Limit of Detection; Linear Models; Plant Extracts; Rats; Rats, Wistar; Reproducibility of Results; Trigonella | 2022 |
Dioscin ameliorates diabetes cognitive dysfunction via adjusting P2X7R/NLRP3 signal.
Topics: Animals; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Diosgenin; Disease Models, Animal; Inflammasomes; Interleukin-1beta; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Receptors, Purinergic P2X7; Signal Transduction | 2021 |
Diosgenin Ameliorated Type II Diabetes-Associated Nonalcoholic Fatty Liver Disease through Inhibiting De Novo Lipogenesis and Improving Fatty Acid Oxidation and Mitochondrial Function in Rats.
Topics: Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Diosgenin; Fatty Acids; Lipogenesis; Liver; Mitochondria; Non-alcoholic Fatty Liver Disease; Rats | 2022 |
Diosgenin attenuates non-alcoholic fatty liver disease in type 2 diabetes through regulating SIRT6-related fatty acid uptake.
Topics: Animals; Diabetes Mellitus, Type 2; Diosgenin; Fatty Acids; Lipid Metabolism; Liver; Mice; Non-alcoholic Fatty Liver Disease; Sirtuins | 2023 |
Effect and possible mechanisms of dioscin on ameliorating metabolic glycolipid metabolic disorder in type-2-diabetes.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Diosgenin; Gene Expression Regulation; Gluconeogenesis; Glycolipids; Hep G2 Cells; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Lipogenesis; Liver; Male; Mice, Inbred C57BL; MicroRNAs; Rats, Wistar; STAT3 Transcription Factor | 2020 |
Dioscin Promotes Proliferation of Pancreatic Beta Cells via Wnt/β-Catenin Signaling Pathways.
Topics: Apoptosis; beta Catenin; Cell Line; Cell Proliferation; Cell Survival; Diabetes Mellitus, Type 2; Diosgenin; Glucose; Glycogen Synthase Kinase 3 beta; Humans; Insulin-Secreting Cells; Wnt Signaling Pathway | 2018 |
Trigonelline and diosgenin attenuate ER stress, oxidative stress-mediated damage in pancreas and enhance adipose tissue PPARγ activity in type 2 diabetic rats.
Topics: Adipose Tissue; Alkaloids; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Diosgenin; Endoplasmic Reticulum Stress; Insulin; Interleukin-6; Leptin; Male; Molecular Docking Simulation; Oxidative Stress; Pancreas; PPAR gamma; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2014 |